European science conversations
by the community, for the community
On 21st November 2017, the European Parliament Science and Technology Options Assessment (STOA) office hosted its annual lecture, chaired by Eva KAILI, MEP and STOA Chair and introduced by Carlos MOEDAS, European Commissioner for Research, Science & Innovation. The Keynote Lecture: How AI and algorithms manage flows of information was delivered by Nello Cristianini, professor of Artificial Intelligence, at the University of Bristol, UK.
Imagine a magazine that constantly edits itself to match the interests of its reader – cutting out all the noise! In an almost magical way, the magazine learns about you as you read and interact with content, and assigns space to each article according to your preferences. Discover NOOWIT a new adaptive media aggregation and magazine publishing platform aimed at solving the information overload of today’s web. It’s the fruit of a lifetime’s work of an entrepreneurial Greek scientist in artificial intelligence, based on a biologically inspired profiling model.
Giulio Sandini, accompanied by a talk by Edgar Körner of the Honda Reserach Institute Europe, gave an insight look into recent developments on the way to learning robots at ESOF2010 in Turin. This thought provoking talk gave the determining factor for this interview.
Artificial intelligence is a rapidly growing field of science and technology, yet the potential it holds for enhancing some of the world’s most powerful experimental tools such as neutron and x-ray probes is yet to be fully explored. Applying machine learning methods to processes within these international experimental facilities could help to overcome some of the biggest challenges faced by scientists today. This includes automating some of the handling, processing, and linking together of large datasets. At Institut Laue-Langevin, exploratory projects are already underway to ensure scattering science also reaps the benefits of artificial intelligence research.
Prof. Hirche and her team are using artificial intelligence to develop advanced robotic systems that can work alongside humans in a safe and intuitive manner.
There are so many innovations waiting to serve scientists that it is quite incredible they have not been adopted sooner. In this insightful opinion piece, Simon Bungers, co-founder of labfolder, an electronic laboratory notebook for researchers, outlines his vision on how scientists’ lives will be transformed by wider adoption of solutions supported by artificial intelligence and the emergence of the likes of blockchain-based solutions to gain greater data reproducibility.
This article is sponsored by
EIT Health
Find out how to become a sponsor
The Wild Card initiative, launched this month by EIT Health, seeks to engage the biggest and brightest minds in implementing ground-breaking and high-risk ideas in healthcare. The two areas of focus for 2018 are: application of artificial intelligence and big data to diagnostics and finding non-pharmaceutical solutions to antibiotic resistance. In this inspired opinion piece, Jan-Philipp Beck, COO at EIT Health, who is based in Munich, Germany, tells us about the main challenges ahead to find solutions to these issues.
The legal implications of the consequences of the actions of robots endowed with artificial intelligence are currently the object of discussion at the European Parliament. In this opinion piece, Orsolya Zara, legal and policy advisor to an MEP at the European Parliament, in Brussels, provides some insights into changes pertaining to robots liability that may need to be implemented in civil law.
After 2008, the global crisis had hit the Greek economy for good and affected academia and its funding. My attempts to fund my R&D work through EU and National projects, or via outside collaborations, were unsuccessful. Despite these setbacks, Greek artificial intelligence scientist Nikolas Nanas decided to turn his PhD work on adaptive information filtering into a real world application that became the NOOWIT magazine platform.
Pharmaceutical analysis is advancing to improve drug discovery and safety. Here are five top pharmaceutical trends driving the sector today.
COVID-19 research papers evidenced the peer review process and is changing the way we assess the quality of scientific literature.
This article presents the science dominant themes beyond coronavirus for 2021, from the perspective of scientist from different disciplines.
EuroScientist journal 
